Literature DB >> 35285683

VP4 Is a Determinant of Alpha-Defensin Modulation of Rotaviral Infection.

Ciara T Hu1, Karina Diaz1, Linda C Yang1, Anjali Sharma1, Harry B Greenberg2, Jason G Smith1.   

Abstract

Fecal-oral pathogens encounter constitutively expressed enteric alpha-defensins in the intestine during replication and transmission. Alpha-defensins can be potently antiviral and antibacterial; however, their primary sequences, the number of isoforms, and their activity against specific microorganisms often vary greatly between species, reflecting adaptation to species-specific pathogens. Therefore, alpha-defensins might influence not only microbial evolution and tissue tropism within a host but also species tropism and zoonotic potential. To investigate these concepts, we generated a panel of enteric and myeloid alpha-defensins from humans, rhesus macaques, and mice and tested their activity against group A rotaviruses, an important enteric viral pathogen of humans and animals. Rotaviral adaptation to the rhesus macaque correlated with resistance to rhesus enteric, but not myeloid, alpha-defensins and sensitivity to human alpha-defensins. While mouse rotaviral infection was increased in the presence of mouse enteric alpha-defensins, two prominent genotypes of human rotaviruses were differentially sensitive to human enteric alpha-defensins. Furthermore, the effects of cross-species alpha-defensins on human and mouse rotaviruses did not follow an obvious pattern. Thus, exposure to alpha-defensins may have shaped the evolution of some, but not all, rotaviruses. We then used a genetic approach to identify the viral attachment and penetration protein, VP4, as a determinant of alpha-defensin sensitivity. Our results provide a foundation for future studies of the VP4-dependent mechanism of defensin neutralization, highlight the species-specific activities of alpha-defensins, and focus future efforts on a broader range of rotaviruses that differ in VP4 to uncover the potential for enteric alpha-defensins to influence species tropism. IMPORTANCE Rotavirus is a leading cause of severe diarrhea in young children. Like other fecal-oral pathogens, rotaviruses encounter abundant, constitutively expressed defensins in the small intestine. These peptides are a vital part of the vertebrate innate immune system. By investigating the impact that defensins from multiple species have on the infectivity of different strains of rotavirus, we show that some rotaviral infections can be inhibited by defensins. We also found that some, but not all, rotaviruses may have evolved resistance to defensins in the intestine of their host species, and some even appropriate defensins to increase their infectivity. Because rotaviruses infect a broad range of animals and rotaviral infections are highly prevalent in children, identifying immune defenses against infection and how they vary across species and among viral genotypes is important for our understanding of the evolution, transmission, and zoonotic potential of these viruses as well as the improvement of vaccines.

Entities:  

Keywords:  defensins; enteric viruses; rotavirus; viral immunity

Mesh:

Substances:

Year:  2022        PMID: 35285683      PMCID: PMC9006894          DOI: 10.1128/jvi.02053-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  58 in total

1.  The cytopathic effects of vervet monkey viruses.

Authors:  H MALHERBE; R HARWIN
Journal:  S Afr Med J       Date:  1963-04-20

2.  MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms.

Authors:  Sudhir Kumar; Glen Stecher; Michael Li; Christina Knyaz; Koichiro Tamura
Journal:  Mol Biol Evol       Date:  2018-06-01       Impact factor: 16.240

3.  Critical determinants of human α-defensin 5 activity against non-enveloped viruses.

Authors:  Anshu P Gounder; Mayim E Wiens; Sarah S Wilson; Wuyuan Lu; Jason G Smith
Journal:  J Biol Chem       Date:  2012-05-25       Impact factor: 5.157

4.  Direct evidence from single-cell analysis that human {alpha}-defensins block adenovirus uncoating to neutralize infection.

Authors:  Emily K Nguyen; Glen R Nemerow; Jason G Smith
Journal:  J Virol       Date:  2010-02-03       Impact factor: 5.103

Review 5.  Rotavirus infection.

Authors:  Sue E Crawford; Sasirekha Ramani; Jacqueline E Tate; Umesh D Parashar; Lennart Svensson; Marie Hagbom; Manuel A Franco; Harry B Greenberg; Miguel O'Ryan; Gagandeep Kang; Ulrich Desselberger; Mary K Estes
Journal:  Nat Rev Dis Primers       Date:  2017-11-09       Impact factor: 52.329

6.  Differential effects on human immunodeficiency virus type 1 replication by alpha-defensins with comparable bactericidal activities.

Authors:  Hiroki Tanabe; Andre J Ouellette; Melanie J Cocco; W Edward Robinson
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination.

Authors:  M M McNeal; R L Broome; R L Ward
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

8.  Defensins Potentiate a Neutralizing Antibody Response to Enteric Viral Infection.

Authors:  Anshu P Gounder; Nicolle D Myers; Piper M Treuting; Beth A Bromme; Sarah S Wilson; Mayim E Wiens; Wuyuan Lu; André J Ouellette; Katherine R Spindler; William C Parks; Jason G Smith
Journal:  PLoS Pathog       Date:  2016-03-02       Impact factor: 6.823

9.  Visualization of Calcium Ion Loss from Rotavirus during Cell Entry.

Authors:  Eric N Salgado; Brian Garcia Rodriguez; Nagarjun Narayanaswamy; Yamuna Krishnan; Stephen C Harrison
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

10.  Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years.

Authors:  Christopher Troeger; Ibrahim A Khalil; Puja C Rao; Shujin Cao; Brigette F Blacker; Tahmeed Ahmed; George Armah; Julie E Bines; Thomas G Brewer; Danny V Colombara; Gagandeep Kang; Beth D Kirkpatrick; Carl D Kirkwood; Jason M Mwenda; Umesh D Parashar; William A Petri; Mark S Riddle; A Duncan Steele; Robert L Thompson; Judd L Walson; John W Sanders; Ali H Mokdad; Christopher J L Murray; Simon I Hay; Robert C Reiner
Journal:  JAMA Pediatr       Date:  2018-10-01       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.